Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Mucilage-ICG for Tumor Delineation in Breast-Conserving Surgery
NCT04438577Unknown
- Sponsor
- Shantou Central Hospital
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine + indocyanine green in breast cancer, sponsored by Shantou Central Hospital. Primary endpoints: Margin width at 7 days and Positive margin rate at 7 days. Status: unknown.
02
Drugs
lidocaine + indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04438577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438577.